JP2024535860A5 - - Google Patents
Info
- Publication number
- JP2024535860A5 JP2024535860A5 JP2024516935A JP2024516935A JP2024535860A5 JP 2024535860 A5 JP2024535860 A5 JP 2024535860A5 JP 2024516935 A JP2024516935 A JP 2024516935A JP 2024516935 A JP2024516935 A JP 2024516935A JP 2024535860 A5 JP2024535860 A5 JP 2024535860A5
- Authority
- JP
- Japan
- Prior art keywords
- disorder
- disorders
- salt
- disease
- schizophrenia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2113186.7 | 2021-09-15 | ||
| GBGB2113186.7A GB202113186D0 (en) | 2021-09-15 | 2021-09-15 | GPR52 Modulator compounds |
| PCT/GB2022/052328 WO2023041909A1 (en) | 2021-09-15 | 2022-09-15 | Gpr52 modulator compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024535860A JP2024535860A (ja) | 2024-10-02 |
| JP2024535860A5 true JP2024535860A5 (enExample) | 2025-09-25 |
Family
ID=78149263
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024516935A Pending JP2024535860A (ja) | 2021-09-15 | 2022-09-15 | Ｇｐｒ５２モジュレーター化合物 |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US20240376070A1 (enExample) |
| EP (1) | EP4401833B1 (enExample) |
| JP (1) | JP2024535860A (enExample) |
| KR (1) | KR20240058852A (enExample) |
| CN (1) | CN117999258A (enExample) |
| AU (1) | AU2022348201A1 (enExample) |
| CA (1) | CA3232606A1 (enExample) |
| CL (1) | CL2024000742A1 (enExample) |
| DK (1) | DK4401833T3 (enExample) |
| ES (1) | ES3053759T3 (enExample) |
| FI (1) | FI4401833T3 (enExample) |
| GB (1) | GB202113186D0 (enExample) |
| HR (1) | HRP20251420T1 (enExample) |
| IL (1) | IL311015A (enExample) |
| LT (1) | LT4401833T (enExample) |
| MX (1) | MX2024003248A (enExample) |
| PL (1) | PL4401833T3 (enExample) |
| PT (1) | PT4401833T (enExample) |
| RS (1) | RS67399B1 (enExample) |
| SI (1) | SI4401833T1 (enExample) |
| SM (1) | SMT202500449T1 (enExample) |
| WO (1) | WO2023041909A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4139284A1 (en) | 2020-04-22 | 2023-03-01 | Neurocrine Biosciences, Inc. | Gpr52 modulators and methods of use |
| WO2025252061A1 (zh) * | 2024-06-04 | 2025-12-11 | 海思科医药集团股份有限公司 | 一种gpr52激动剂及其在医药上的应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2009107391A1 (ja) * | 2008-02-27 | 2011-06-30 | 武田薬品工業株式会社 | ６員芳香環含有化合物 |
| MX373876B (es) | 2015-04-29 | 2020-03-26 | Arena Pharm Inc | 1-heteroaril-indolin-4-carboxamidas como moduladores de gpr52 útiles para el tratamiento o prevención de trastornos relacionados a las mismas. |
| CN111094278B (zh) * | 2017-09-13 | 2023-07-14 | 诺华股份有限公司 | 二苯基衍生物及其用途 |
| CN114650992A (zh) * | 2019-11-08 | 2022-06-21 | 赫普泰雅治疗有限公司 | Gpr52调节剂化合物 |
| GB202003668D0 (en) | 2020-03-13 | 2020-04-29 | Heptares Therapeutics Ltd | GPR52 Modulator compounds |
-
2021
- 2021-09-15 GB GBGB2113186.7A patent/GB202113186D0/en not_active Ceased
-
2022
- 2022-09-15 KR KR1020247006746A patent/KR20240058852A/ko active Pending
- 2022-09-15 PL PL22778038.4T patent/PL4401833T3/pl unknown
- 2022-09-15 DK DK22778038.4T patent/DK4401833T3/da active
- 2022-09-15 SI SI202230201T patent/SI4401833T1/sl unknown
- 2022-09-15 US US18/689,590 patent/US20240376070A1/en active Pending
- 2022-09-15 AU AU2022348201A patent/AU2022348201A1/en active Pending
- 2022-09-15 SM SM20250449T patent/SMT202500449T1/it unknown
- 2022-09-15 HR HRP20251420TT patent/HRP20251420T1/hr unknown
- 2022-09-15 IL IL311015A patent/IL311015A/en unknown
- 2022-09-15 ES ES22778038T patent/ES3053759T3/es active Active
- 2022-09-15 CA CA3232606A patent/CA3232606A1/en active Pending
- 2022-09-15 PT PT227780384T patent/PT4401833T/pt unknown
- 2022-09-15 JP JP2024516935A patent/JP2024535860A/ja active Pending
- 2022-09-15 WO PCT/GB2022/052328 patent/WO2023041909A1/en not_active Ceased
- 2022-09-15 EP EP22778038.4A patent/EP4401833B1/en active Active
- 2022-09-15 RS RS20251139A patent/RS67399B1/sr unknown
- 2022-09-15 LT LTEPPCT/GB2022/052328T patent/LT4401833T/lt unknown
- 2022-09-15 CN CN202280062419.2A patent/CN117999258A/zh active Pending
- 2022-09-15 MX MX2024003248A patent/MX2024003248A/es unknown
- 2022-09-15 FI FIEP22778038.4T patent/FI4401833T3/fi active
-
2024
- 2024-03-13 CL CL2024000742A patent/CL2024000742A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20241375T1 (hr) | Spojevi modulatora gpr52 | |
| AU658898B2 (en) | Substituted 3-aminoquinuclidines | |
| JP6839104B2 (ja) | ウイルス感染の治療及び予防のための新規な置換アミノチアゾロピリミジンジオン | |
| JP2023519666A5 (enExample) | ||
| TWI431004B (zh) | Ｂａｃｅ抑制劑 | |
| IL295364A (en) | Psilocin derivatives as serotonergic psychedelic agents for the treatment of cns disorders | |
| SG11202109020QA (en) | N-substituted indoles and other heterocycles for treating brain disorders | |
| CN119212699A (zh) | Nlrp3抑制剂 | |
| JP2012522793A5 (enExample) | ||
| JP2018536634A5 (enExample) | ||
| JP2018504437A5 (enExample) | ||
| EP4428136B1 (en) | Improved synthetic methods of making fused heterocyclic compounds as orexin receptor modulators | |
| JP2023539336A5 (enExample) | ||
| CN109311801A (zh) | (2r,6r)-羟基去甲氯胺酮和(2s,6s)-羟基去甲氯胺酮的晶型和合成方法 | |
| ES2289533T3 (es) | Derivados de indol con una actividad antipsicotica mejorada. | |
| JP2023534803A5 (enExample) | ||
| JP2021501183A (ja) | 二環式のスルホン及びスルホキシド、並びにその使用方法 | |
| HRP20251420T1 (hr) | Gpr52 modulatorski spojevi | |
| JP2017523201A5 (enExample) | ||
| CN1026489C (zh) | 抗鼻病毒的(硫代)吗啉基和哌嗪基烷基酚醚的制备方法 | |
| JP2024535343A5 (enExample) | ||
| JP2008208114A5 (enExample) | ||
| JP2008500315A (ja) | 抗菌剤としての、３−［４−（６−｛４，５−ジヒドロイソオキサゾール−３−イル｝ピリジン−３−イル）−３−フェニル］−５−（１ｈ−１，２，３−トリアゾール−１−イルメチル）−１，３−オキサゾリジン−２−オン | |
| RU2024109992A (ru) | Соединения-модуляторы gpr52 | |
| WO2007003965A1 (en) | Substituted cyclohexyl derivatives as nk-3 receptor antagonists |